Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Valuation -- Ignore unavailable to you. Want to Upgrade?

To: olivier benrubi who wrote (1030)	4/28/2000 10:22:00 AM
From: Biomaven	Read Replies (1) \| Respond to of 52153

See the SEPR thread for a discussion of the possible liquidation of Soros's Quantum Fund: Message 13517355 Here's a link to one report: hoovershbn.hoovers.com This may be an explanation for some of the excessive weakness in some biotech stocks of late. The fund used to have substantial holdings in a number of biotechs - e.g., SEPR, PCYC, IGEN, PDLI, VIRS, VPHM and others. (Do I detect a complete overlap with a bunch of my present and past holdings? <g>). Some of these holdings have disappeared from public record because they fell under 5%, but that doesn't imply they were all gone. From a timing perspective, it is possible that the selling from this fund may already be over - OTOH of course it may not be. From a value-oriented perspective, buying into someone else's forced selling is of course ideal. From a momentum perspective, it is of course death. In this situation, I'd be firmly on the valuation side. Peter